Detalhe da pesquisa
1.
Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment.
AIDS
; 36(2): 185-194, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34261093